Accessibility Menu

BioScience Health Innovations(OTC) BHIC

Market Cap$58.17MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2021)+125%
5 Year-62%
1 Year+24%
1 Month+20%
$4.95
+8.79%
+0.40Today
BioScience Health Innovations last closing stock price
MetricPriceDate
Last closeUSD 4.952026-08-31
BioScience Health Innovations stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+21.92%USD 4.062026-08-24
1 month+20.44%USD 4.112026-07-31
3 month+21.03%USD 4.092026-06-02
Year to date+395%USD 1.002025-09-29
1 year+23.75%USD 4.002025-07-18
3 year-86.27%USD 36.042023-05-04
5 year-61.57%USD 12.882021-07-09
Since inception+125%USD 2.202021-06-17

BioScience Health Innovations Financials at a Glance

Market Cap

$58.17MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$4.49

Net Income (TTM)

-$0.66

EPS (TTM)

-$0.06

P/E Ratio

-85.05

Dividend

$0.00

Beta (Volatility)

0.58 (Low)

Price

$4.95

Volume

26,207

Open

$4.55

Previous Close

$4.95

Daily Range

$4.41 - $4.95

52-Week Range

$1.00 - $9.98

Estimated Earnings Date

N/A

BHIC News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About BioScience Health Innovations

Nowtransit, Inc. is a development stage company, which intends to seek new business opportunities. The company was founded on July 8, 2019 and is headquartered in Salt Lake City, Utah.

Industry

Healthcare Providers and Services

Sector

Health Care

CEO

Darren J. Lopez, MBA

Website

www.nowtransitinc.com

BHIC Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

-37.03%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

-1.18%

Dividend Yield

0.00%

Payout Ratio

N/A

Stock Overview

Market Cap

$58.17MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

11.75M

Volume

26.21K

Avg. Volume

6.47K

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

BioScience Health Innovations Performance Analysis

BioScience Health Innovations annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-08-31USD 0N/A
20232023-12-31USD 597,595N/A
20242024-12-31USD 1,844,966208.7%
20252025-12-31USD 5,688,717208.3%
BioScience Health Innovations annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-08-31USD -0.02223.4%
20232023-12-31USD -0.01-51.3%
20242024-12-31USD 0.00N/A
20252025-12-31USD 0.062715.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$1.04

+0.6%

Gross Profit

$0.66

+0.6%

Gross Margin

63.63%

+1.0%

Market Cap

$58.17MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

N/A

N/A

Net Income

-$0.19

-0.4%

EBITDA

-$0.22

-0.5%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$0.97

-25.1%

Total Debt

$0.26

N/A

Accounts Receivable

$0.40

+1.0%

Inventory

$0.80

+3.2%

Long Term Debt

$0.00

N/A

Short Term Debt

$0.26

N/A

Return on Assets

-31.39%

-0.4%

Return on Invested Capital

1258.10%

+0.7%

Free Cash Flow

-$0.54

-1.8%

Operating Cash Flow

-$0.54

-1.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,684.24-0.00%
^DJIDJI
$53,254.61-0.01%
^IXICNASDAQ
$26,319.55-0.00%
BTCBitcoin
$78,890.00-0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
PCGPG&E
$13.27-0.20%
NVDANvidia
$220.78+0.01%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.97+0.11%
CNHCNH Industrial
$11.83+0.01%

Questions About BHIC

What is the current price of BioScience Health Innovations?

BioScience Health Innovations is trading at $4.95 per share.

What is the 52-week range for BioScience Health Innovations?

Over the past 52 weeks, BioScience Health Innovations has traded between $1.00 and $9.98.

How much debt does BioScience Health Innovations have?

As of the most recent reporting period, BioScience Health Innovations reported total debt of $260.40K.

How much cash does BioScience Health Innovations have on hand?

BioScience Health Innovations reported $712.38K in cash and cash equivalents in its most recent financial results.

What is BioScience Health Innovations’s dividend yield?

BioScience Health Innovations does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services